Atlas Trials

A Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions

Clinical trial NCT06578455 · COMPLETED

Trial details

NCT number
NCT06578455
Sponsor
dsm-firmenich Switzerland AG
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
CBD PharmacokineticsHealthy Participants
Start date
2024-08-30
Primary completion
2024-11-20
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.